Literature DB >> 26540592

Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection.

Julie E Bauman1, Jennifer Grandis2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 26540592     DOI: 10.1001/jamaoncol.2015.4637

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  9 in total

Review 1.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

2.  When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials.

Authors:  Daniel E Johnson; Julie E Bauman
Journal:  Cancer Prev Res (Phila)       Date:  2017-08-18

3.  Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

Authors:  Thomas W Kensler; Avrum Spira; Judy E Garber; Eva Szabo; J Jack Lee; Zigang Dong; Andrew J Dannenberg; William N Hait; Elizabeth Blackburn; Nancy E Davidson; Margaret Foti; Scott M Lippman
Journal:  Cancer Prev Res (Phila)       Date:  2016-01

4.  Precancer Atlas to Drive Precision Prevention Trials.

Authors:  Avrum Spira; Matthew B Yurgelun; Ludmil Alexandrov; Anjana Rao; Rafael Bejar; Kornelia Polyak; Marios Giannakis; Ali Shilatifard; Olivera J Finn; Madhav Dhodapkar; Neil E Kay; Esteban Braggio; Eduardo Vilar; Sarah A Mazzilli; Timothy R Rebbeck; Judy E Garber; Victor E Velculescu; Mary L Disis; Douglas C Wallace; Scott M Lippman
Journal:  Cancer Res       Date:  2017-04-01       Impact factor: 13.312

Review 5.  The Conundrum of Genetic "Drivers" in Benign Conditions.

Authors:  Shumei Kato; Scott M Lippman; Keith T Flaherty; Razelle Kurzrock
Journal:  J Natl Cancer Inst       Date:  2016-04-07       Impact factor: 13.506

6.  Immunological and classical subtypes of oral premalignant lesions.

Authors:  Jean-Philippe Foy; Chloé Bertolus; Sandra Ortiz-Cuaran; Marie-Alexandra Albaret; William N Williams; Wenhua Lang; Solène Destandau; Geneviève De Souza; Emilie Sohier; Janice Kielbassa; Emilie Thomas; Sophie Deneuve; Patrick Goudot; Alain Puisieux; Alain Viari; Li Mao; Christophe Caux; S M Lippman; P Saintigny
Journal:  Oncoimmunology       Date:  2018-09-21       Impact factor: 7.723

Review 7.  Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective.

Authors:  Danijel Galun; Dragana Mijac; Aleksandar Filipovic; Aleksandar Bogdanovic; Marko Zivanovic; Dragan Masulovic
Journal:  J Pers Med       Date:  2022-01-24

Review 8.  Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.

Authors:  Naoto Fujiwara; Scott L Friedman; Nicolas Goossens; Yujin Hoshida
Journal:  J Hepatol       Date:  2017-10-06       Impact factor: 30.083

9.  Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions.

Authors:  J Silvio Gutkind; Alfredo A Molinolo; Xingyu Wu; Zhiyong Wang; Daniela Nachmanson; Olivier Harismendy; Ludmil B Alexandrov; Beverly R Wuertz; Frank G Ondrey; Denise Laronde; Leigha D Rock; Miriam Rosin; Charles Coffey; Valerie D Butler; Lisa Bengtson; Chiu-Hsieh Hsu; Julie E Bauman; Stephen M Hewitt; Ezra Ew Cohen; H-H Sherry Chow; Scott M Lippman; Eva Szabo
Journal:  JCI Insight       Date:  2021-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.